ArticleMovement disorders : official journal of the Movement Disorder Society2022
Reply to: "Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1-Associated Parkinson's Disease".
Adenrele M Gleason et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.